Cipla Bleomycin 7,5 mg Powder for solution for injection.
PDF Leaflet Revision Date: 09 November 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of squamous cell carcinomas and certain lymphomas.
Dosage (summary)
0.25 to 0.5 units/kg weekly or twice weekly; maintenance 1 unit daily or 5 units weekly.
Special Populations
- Renal impairment
- Elderly patients
- Pulmonary impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; reliable contraception required.
Key Drug Interactions
- Cisplatin
- Vinca alkaloids
- Granulocyte Colony-Stimulating Factor
Contraindications
- Hypersensitivity to bleomycin
- Pregnancy
- Lactation
Common side effects
- Pulmonary toxicity
- Cutaneous reactions
- Nausea
- Fever
Counselling Points
- Avoid pregnancy during treatment
- Monitor for pulmonary symptoms
- Report any severe skin reactions
Serious warnings
- Risk of pulmonary toxicity
- Monitor lung function
- Caution in renal impairment
On This Page
Loading package insert…
Medinsert AI
Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
